Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Oxford Finance’s Leveraged Lending Group Closes More Than $1.4 BN of Capital Commitments in 2021
Life Sciences Times
-
January 25, 2022
0
Venture Capital
Alira Health Expands its Digital Health Portfolio with the Acquisition of Self Care Catalysts
Life Sciences Times
-
January 25, 2022
0
Venture Capital
Hercules Capital Closes Upsized Public Offering of $350.0 Million 3.375% Notes Due 2027
Life Sciences Times
-
January 21, 2022
0
Venture Capital
Francisco Partners to Acquire IBM’s Healthcare Data and Analytics Assets
Life Sciences Times
-
January 21, 2022
0
Venture Capital
BigTime Software Receives $100 Million Strategic Growth Investment From Vista Equity Partners
Life Sciences Times
-
January 20, 2022
0
Venture Capital
ONI Closes $75 Million Series B Led by ARCH Venture Partners and Casdin Capital
Life Sciences Times
-
January 20, 2022
0
Venture Capital
64x Bio Raises $55 Million Series A Financing to Advance Cell Line Engineering Platform for Gene Therapy Manufacturing
Life Sciences Times
-
January 19, 2022
0
Venture Capital
Xcellbio Announces $27.5 Million Series B Financing
Life Sciences Times
-
January 19, 2022
0
Venture Capital
Ceptur Therapeutics Launches with $75M Series A Financing to Advance RNA Therapeutics Based on Proprietary U1 Adaptor Technology
Life Sciences Times
-
January 19, 2022
0
Biotech
Bruker Acquires Prolab Instruments to Augment Multiomics Solutions
Life Sciences Times
-
January 19, 2022
0
Venture Capital
Schrocken Inc. Raises Undisclosed Funding From Deep-Tech funds Five Gardens LLC, ThinKuvate and Their Existing Investors
Life Sciences Times
-
January 18, 2022
0
Venture Capital
VistaVu Acquires R Tech to Boost Customer Experience Commitment
Life Sciences Times
-
January 18, 2022
0
1
...
87
88
89
...
115
Page 88 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026